AstraZeneca revenue surges $11.39 billion, but sees COVID vaccine sales decline
By Cecilia Butini AstraZeneca PLC said Friday that it expects sales of its Covid-19 medicines, including its vaccine, to decline by a low-to-mid twenties percentage during the year, but reported higher revenue in the first quarter on the back of previous vaccine contracts.
The Anglo-Swedish pharma giant said that revenue rose to $11.39 billion in the first quarter from $7.32 billion the year prior, due to contribution from medicines of acquired company Alexion Pharmaceuticals and Covid-19 vaccine contracts that are awaiting delivery this year. The company said that earnings before interest, taxes, depreciation and amortization were negatively affected by a $1.18 billion unwind of investory fair value uplift recognized on the acquisition of Alexion. The metric was $2.19 billion in the quarter, down from $2.69 billion the year prior.Core earnings per share rose to $1.89 in the quarter, a 16% increase from the previous year, AstraZeneca said.
Looking ahead, AstraZeneca said that it expects total revenue to increase by a high-teens percentage in 2022, while core EPS is expected to increase by a mid-to-high twenties percentage. Considering the expected decline in the sales of Covid-19 medicines, however, AstraZeneca said that gross margin from those medicines is expected to be lower than company average.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Mark Zuckerberg got $11 billion richer todayNearly two months after losing his spot among the world's 10 richest rich people, Mark Zuckerberg is clawing his way back.
Lire la suite »
Boeing CEO talks China crash, 737 Max jet after 1Q lossBoeing reported an overall net loss of $1.2 billion during the quarter, or $2.75 per share. Total revenue came in at $13.99 billion
Lire la suite »
Mark Zuckerberg got $11 billion richer todayNearly two months after losing his spot among the world's 10 richest rich people, Mark Zuckerberg is clawing his way back.
Lire la suite »
Unilever 1Q Underlying Sales Growth Up 7.3%By Michael Susin Unilever PLC said Thursday that first-quarter turnover and sales rose above market expectations despite higher input costs, which it expects...
Lire la suite »
Trailblazing Chicago priest accused of molesting boy in the 1970sA Black priest who was a civil rights hero to many African American Catholics has been accused of being an alleged sexual abuser of a young boy in an $800,000 settlement reached with the Archdiocese of Chicago, according to a lawyer for the boy.
Lire la suite »